Quest Diagnostics is set to offer an FDA-cleared blood test for Alzheimer’s disease developed by Fujirebio. Building on its pioneering AD-Detect™ product line, the test will be available for clinical and research use as soon as this summer, marking a significant advancement in assessing symptomatic patients.

New research suggests that physical exercise can make your brain act up to four years younger, offering promising strategies to reduce the risk of dementia and Alzheimer’s disease. Even minimal daily activity may provide significant cognitive benefits, highlighting the profound impact of exercise on brain health.

As we age, understanding dementia and Alzheimer’s disease becomes crucial for maintaining cognitive health. This article explores these conditions, their signs, risk factors, and tips to reduce the risk, empowering seniors and their families with essential knowledge.